Equities
  • Price (EUR)0.0572
  • Today's Change-0.003 / -4.67%
  • Shares traded3.08m
  • 1 Year change-53.87%
  • Beta-0.3397
Data delayed at least 15 minutes, as of Feb 13 2026 16:37 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Substrate Artificial Inteligence SA is a Spain-based digital solutions provider. The Company's activities include Computer programming, The design of structures and the content and the writing of the computer code necessary to create and implement: Programs for systems, Computer applications, Databases, Web pages (including patches and updates). The Company works towards client's customized software requirements. Furthermore The Company provides preparation of investment reports and financial analyses or other forms of general, non-customized recommendations relating to transactions in financial instruments, and financial mediation services, including the channeling of such transactions, taking all the necessary steps with the authorities, entities, financial intermediaries and notaries that must intervene, including the control and follow-up of the actions.

  • Revenue in EUR (TTM)18.71m
  • Net income in EUR7.57m
  • Incorporated2011
  • Employees27.00
  • Location
    Substrate Artificial Inteligence SAC/ Maria de Molina, 41, Oficina 503MADRID 28006SpainESP
  • Phone+34 961237015
  • Websitehttps://substrate.ai/es/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SAI:MCE since
announced
Transaction
value
Developingtalent SrlDeal completed03 Jul 202503 Jul 2025Deal completed-42.80%1.80m
Secure HRDeal completed13 Jun 202513 Jun 2025Deal completed-52.33%--
Data delayed at least 15 minutes, as of Feb 13 2026 16:37 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Clinical Laserthermia Systems AB2.01m-3.62m23.84m16.00--3.49--11.87-5.02-5.021.082.320.32084.584.841,329,313.00-57.98-116.28-63.60-248.44-63.75-556.78-180.75-872.822.55-5.790.0039--127.0467.4740.32------
Mauna Kea Technologies SA7.48m-10.39m24.17m61.00------3.23-0.1407-0.14070.1015-0.36890.48541.194.59115,015.40-68.47-47.72---149.1943.2018.06-141.06-129.390.1177--9.54---26.960.5957-179.15---31.06--
IMD International Medical Devices SpA36.29m1.34m24.35m121.0017.821.0811.760.6710.07750.07752.101.271.011.774.72299,918.503.46--4.97--24.88--3.42--1.74--0.0185--3.49--0.5537------
Ikonisys SA617.19k-2.70m25.35m10.00--1.06--41.07-0.1334-0.13340.06091.510.02520.81033.4061,719.00-11.01---14.76--0.943---437.39--0.0691-30.680.1686---27.28--7.38------
INIFY Laboratories AB1.90m-5.80m26.00m34.00--2.10--13.67-1.14-1.140.37051.720.19282.963.12858,106.10-58.78---58.78--85.20---304.93------0.00--1,000.67--3.15------
Aptamer Group PLC1.38m-2.79m27.14m31.00--12.61--19.62-0.0014-0.00140.00070.00070.42946.274.3538,806.45-86.53---154.00--48.13---201.50--1.48-84.630.2622--39.88--18.05------
Otofarma SpA-100.00bn-100.00bn28.84m75.00--5.63----------0.8608------------------------1.68--0.247--------------
Karolinska Development AB164.12k-12.82m29.38m8.00--0.1007--179.00-0.4096-0.40960.00523.280.0015--0.6263217,250.00-11.69-2.23-11.78-2.37-----7,810.36-1,161.99---1.490.0017---8.74-11.49-250.41------
Acarix AB653.27k-4.95m31.82m8.00--8.76--48.71-0.0472-0.04720.00620.03430.11960.16672.77864,750.00-90.68-74.33-102.27-86.4786.1582.37-757.98-1,298.777.93-805.720.00---0.624927.2814.97------
Implanet SA11.10m-4.81m32.93m44.00------2.97-0.038-0.0380.0876-0.01080.74320.86185.06253,379.00-32.23-37.85-176.46-98.0252.1158.59-43.36-68.070.2485--1.29--26.314.8921.87--25.84--
Substrate Artificial Inteligence SA18.71m7.57m34.23m27.000.59740.15373.931.830.09580.09580.19720.37220.31961.523.88693,097.8012.30--17.59--86.07--38.49--0.62493.830.0919--103.54--183.37------
Mentice AB25.92m-4.09m34.39m121.00--2.89--1.33-1.68-1.6810.524.480.96631.603.942,095,328.00-15.25-6.64-31.60-11.9190.4084.80-15.78-8.530.845-30.100.116--6.1114.22-553.89--32.86--
Diagnostic Medical Systems SA46.77m-1.67m35.45m140.00--2.2139.080.7579-0.069-0.0692.050.60060.8761.844.52324,798.60-2.86-11.47-5.81-20.5239.7938.72-3.27-14.950.6154-0.52030.5811--9.298.2470.50------
Theraclion SA1.90m-5.25m36.08m33.00------18.96-0.1127-0.11270.0408-0.05480.14790.33048.7459,455.31-40.84-33.44-55.80-47.3354.0166.95-276.15-360.911.79-67.332.50---54.44-21.49-56.66---4.97--
Ortoma AB7.29m-709.98k43.15m10.00--2.9087.505.92-0.2027-0.20272.084.450.42433.9539.137,530,537.00-4.13-9.37-4.45-10.4341.26158.24-9.74-78.903.02--0.00--28.77--46.83---0.5751--
Q linea AB1.05m-17.23m43.17m83.00--1.35--41.19-35.87-35.871.3117.840.04290.40062.90---70.50-76.00-101.81-93.84-15.26-145.47-1,644.30-2,820.5110.04-30.480.017--369.86114.7515.86---34.47--
Data as of Feb 13 2026. Currency figures normalised to Substrate Artificial Inteligence SA's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.